{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:30:12Z","timestamp":1790281812959,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Inserm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"CNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institut Pasteur de Lille"},{"name":"University of Lille and Inserm-Transfert"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:31:54Z","timestamp":1557408714000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir"],"prefix":"10.1016","volume":"168","author":[{"given":"Anne-France","family":"Georgel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Cayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Pizzorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rosa-Calatrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Sencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1626-7693","authenticated-orcid":false,"given":"Jean","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Trottein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-4652","authenticated-orcid":false,"given":"Jean-Claude","family":"Sirard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Carnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.05.002_bib1","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1016\/j.vaccine.2015.07.070","article-title":"Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens","volume":"33","author":"Barjesteh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.05.002_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.immuni.2012.11.004","article-title":"The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response","volume":"38","author":"Blanc","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.05.002_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.05.002_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.194.2.181","article-title":"Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection","volume":"194","author":"Collazo","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.05.002_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/mi.2011.63","article-title":"Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16","volume":"5","author":"Conrady","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.20070891","article-title":"Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection","volume":"205","author":"Didierlaurent","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.05.002_bib7","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.antiviral.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.vaccine.2015.05.022","article-title":"Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract","volume":"33","author":"Fougeron","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.05.002_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.antiviral.2013.02.013","article-title":"Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring","volume":"98","author":"Govorkova","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.002_bib11","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1128\/JVI.00187-10","article-title":"Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2006.07.011","article-title":"Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats","volume":"73","author":"Hammerbeck","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.002_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrmicro2745","article-title":"Modulating immunity as a therapy for bacterial infections","volume":"10","author":"Hancock","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib14","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/JCM.43.8.4139-4146.2005","article-title":"Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor","volume":"43","author":"Hatakeyama","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1473-3099(11)70099-8","article-title":"Targeting of Toll-like receptors: a decade of progress in combating infectious diseases","volume":"11","author":"Hedayat","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096165","article-title":"Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice","volume":"9","author":"Hossain","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.002_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1128\/JVI.02943-12","article-title":"Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection","volume":"87","author":"Ivanov","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib21","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/IAI.01196-10","article-title":"Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis","volume":"79","author":"Jarchum","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2019.05.002_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2010.11.013","article-title":"CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model","volume":"89","author":"Jiang","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.002_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/650203","article-title":"Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection","volume":"201","author":"Kinnebrew","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.002_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.immuni.2011.12.011","article-title":"Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense","volume":"36","author":"Kinnebrew","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.05.002_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2010.07.008","article-title":"Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice","volume":"406","author":"Lau","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.05.002_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2017.10.035","article-title":"Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir","volume":"818","author":"Leiva-Juarez","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1073\/pnas.0607038104","article-title":"IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses","volume":"104","author":"Lenschow","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.002_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.05.002_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176355","article-title":"Transcriptomic profiling of a chicken lung epithelial cell line (CLEC213) reveals a mitochondrial respiratory chain activity boost during influenza virus infection","volume":"12","author":"Meyer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.002_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2014.00079","article-title":"TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease","volume":"5","author":"Mifsud","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/icb.2015.81","article-title":"Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys","volume":"94","author":"Mifsud","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib33","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.jmb.2013.09.041","article-title":"The antiviral activities of ISG15","volume":"425","author":"Morales","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","author":"Mordstein","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.002_bib35","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/IAI.00224-10","article-title":"Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection","volume":"78","author":"Munoz","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2019.05.002_bib36","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.181.3.2036","article-title":"Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity","volume":"181","author":"Nempont","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib37","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/JVI.01805-09","article-title":"Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model","volume":"84","author":"Norton","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib38","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1074\/jbc.M111.304758","article-title":"Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages","volume":"287","author":"Paget","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.05.002_bib39","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1128\/AAC.01210-15","article-title":"A toll-like receptor 5 agonist improves the efficacy of antibiotics in treatment of primary and influenza virus-associated pneumococcal mouse infections","volume":"59","author":"Porte","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.05.002_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","article-title":"Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases","volume":"4","author":"Savva","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib42","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1021\/mp300257x","article-title":"Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice","volume":"9","author":"Tan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.antiviral.2019.05.002_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030596","article-title":"Synergistic TLR2\/6 and TLR9 activation protects mice against lethal influenza pneumonia","volume":"7","author":"Tuvim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.002_bib44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4049\/jimmunol.1000115","article-title":"TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa","volume":"185","author":"Van Maele","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/mi.2013.66","article-title":"Airway structural cells regulate TLR5-mediated mucosal adjuvant activity","volume":"7","author":"Van Maele","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/infdis\/jiu106","article-title":"Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection","volume":"210","author":"Van Maele","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.002_bib47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tim.2017.10.008","article-title":"Compartmentalized antimicrobial defenses in response to flagellin","volume":"26","author":"Vijayan","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/v9120376","article-title":"Host cell restriction factors that limit influenza a infection","volume":"9","author":"Villalon-Letelier","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.05.002_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.05.002_bib50","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.vaccine.2009.01.048","article-title":"Activation of toll-like receptor signaling pathway for protection against influenza virus infection","volume":"27","author":"Wong","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.05.002_bib51","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1073\/pnas.0611624104","article-title":"Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand","volume":"104","author":"Wu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.002_bib52","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4049\/jimmunol.1000509","article-title":"Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide","volume":"185","author":"Yu","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.002_bib53","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.1256999","article-title":"Viral infection. Prevention and cure of rotavirus infection via TLR5\/NLRC4-mediated production of IL-22 and IL-18","volume":"346","author":"Zhang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.05.002_bib54","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.01410-12","article-title":"Intranasal treatment with poly(I*C) protects aged mice from lethal respiratory virus infections","volume":"86","author":"Zhao","year":"2012","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218305709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218305709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:47Z","timestamp":1759062467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218305709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":52,"alternative-id":["S0166354218305709"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}